Monocytes from chronic HBV patients react in vitro to HBsAg and TLR by producing cytokines irrespective of stage of disease

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Boltjes, Arjan ^a   Groothuismink, Zwier M ^a   Van Oord, Gertine W ^a   Janssen, Harry L A ^a,b   Woltman, Andrea M ^a   Boonstra, André ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 6; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; VIRUS DNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL COMPOSITION; CELL FUNCTION; CHRONIC HEPATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PHENOTYPE; PROTEIN BLOOD LEVEL; ADOLESCENT; BIOSYNTHESIS; BLOOD; IMMUNOLOGY; MIDDLE AGED; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; FEMALE; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; MONOCYTES; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84901273249     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097006     Document Type: Article

References (34)

1. Ott JJ, Stevens GA, Groeger J, Wiersma ST (2012) Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 30: 2212-2219.
2. Boonstra A, Woltman AM, Janssen HL (2008) Immunology of hepatitis B and hepatitis C virus infections. Best Pract Res Clin Gastroenterol 22: 1049-1061.
3. Ganem D, Prince AM (2004) Hepatitis B virus infection - natural history and clinical consequences. N Engl J Med 350: 1118-1129. (Pubitemid 38298992)
4. Rehermann B, Nascimbeni M (2005) Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5: 215-229.v
5. Nockher WA, Bergmann L, Scherberich JE (1994) Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients. Clin Exp Immunol 98: 369-374. (Pubitemid 24374718)
6. Nockher WA, Scherberich JE (1998) Expanded CD14+ CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis. Infect Immun 66: 2782-2790. (Pubitemid 28261784)
7. Liu BS, Groothuismink ZM, Janssen HL, Boonstra A (2011) Role for IL-10 in inducing functional impairment of monocytes upon TLR4 ligation in patients with chronic HCV infections. J Leukoc Biol 89: 981-988.
8. Peng C, Liu BS, de Knegt RJ, Janssen HL, Boonstra A (2011) The response to TLR ligation of human CD16(+)CD14(-) monocytes is weakly modulated as a consequence of persistent infection with the hepatitis C virus. Mol Immunol 48: 1505-1511.
9. Auffray C, Sieweke MH, Geissmann F (2009) Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 27: 669-692.
10. Cros J, Cagnard N, Woollard K, Patey N, Zhang SY, et al. (2010) Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 33: 375-386.
11. Anthony DD, Umbleja T, Aberg JA, Kang M, Medvik K, et al. (2011) Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals. Vaccine 29: 3558-3563.
12. Zhang JY, Zou ZS, Huang A, Zhang Z, Fu JL, et al. (2011) Hyper-activated pro-inflammatory CD16 monocytes correlate with the severity of liver injury and fibrosis in patients with chronic hepatitis B. PLoS ONE 6: e17484.
13. Visvanathan K, Skinner NA, Thompson AJV, Riordan SM, Sozzi V, et al. (2007) Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 45: 102-110. (Pubitemid 46150869)
14. Riordan SM, Skinner N, Kurtovic J, Locarnini S, Visvanathan K (2006) Reduced Expression of Toll-Like Receptor 2 on Peripheral Monocytes in Patients with Chronic Hepatitis B. Clinical and Vaccine Immunology 13: 972-974. (Pubitemid 44409640)
15. Vanlandschoot P, Roobrouck A, Van Houtte F, Leroux-Roels G (2002) Recombinant HBsAg, an apoptotic-like lipoprotein, interferes with the LPS-induced activation of ERK-1/2 and JNK-1/2 in monocytes. Biochem Biophys Res Commun 297: 486-491.
16. Shi B, Ren G, Hu Y, Wang S, Zhang Z, et al. (2012) HBsAg inhibits IFN-alpha production in plasmacytoid dendritic cells through TNF-alpha and IL-10 induction in monocytes. PLoS ONE 7: e44900.
17. Roederer M, Nozzi JL, Nason MC (2011) SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 79: 167-174.
18. Wu JF, Wu TC, Chen CH, Ni YH, Chen HL, et al. (2010) Serum levels of interleukin-10 and interleukin-12 predict early, spontaneous hepatitis B virus e antigen seroconversion. Gastroenterology 138: 165-172 e161-163.
19. Tulek N, Saglam SK, Saglam M, Turkyilmaz R, Yildiz M (2000) Soluble interleukin-2 receptor and interleukin-10 levels in patients with chronic hepatitis B infection. Hepatogastroenterology 47: 828-831. (Pubitemid 30417303)
20. Bozkaya H, Bozdayi M, Turkyilmaz R, Sarioglu M, Cetinkaya H, et al. (2000) Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease. Hepatogastroenterology 47: 1675-1679.
21. Peppa D, Micco L, Javaid A, Kennedy PT, Schurich A, et al. (2010) Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection. PLoS Pathog 6: e1001227.
22. Dunn C, Peppa D, Khanna P, Nebbia G, Jones M, et al. (2009) Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 137: 1289-1300.
23. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19: 683-765. (Pubitemid 32368050)
24. Liu BS, Janssen HL, Boonstra A (2012) Type I and III interferons enhance IL-10R expression on human monocytes and macrophages, resulting in IL-10-mediated suppression of TLR-induced IL-12. Eur J Immunol 42: 2431-2440.
25. Shi M, Qian S, Chen WW, Zhang H, Zhang B, et al. (2007) Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro. Clin Exp Immunol 147: 277-286. (Pubitemid 46096006)
26. Cheng J, Imanishi H, Morisaki H, Liu W, Nakamura H, et al. (2005) Recombinant HBsAg inhibits LPS-induced COX-2 expression and IL-18 production by interfering with the NF[kappa]B pathway in a human monocytic cell line, THP-1. Journal of Hepatology 43: 465-471. (Pubitemid 41111428)
27. Jochum C, Voth R, Rossol S, Meyer zum Buschenfelde KH, Hess G, et al. (1990) Immunosuppressive function of hepatitis B antigens in vitro: role of endoribonuclease V as one potential trans inactivator for cytokines in macrophages and human hepatoma cells. J Virol 64: 1956-1963. (Pubitemid 20148436)
28. Op den Brouw ML, Binda RS, van Roosmalen MH, Protzer U, Janssen HL, et al. (2009) Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus. Immunology 126: 280-289.
29. Woltman AM, Op den Brouw ML, Biesta PJ, Shi CC, Janssen HL (2011) Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function. PLoS ONE 6: e15324.
30. Xu Y, Hu Y, Shi B, Zhang X, Wang J, et al. (2009) HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells. Mol Immunol 46: 2640-2646.
31. Vanlandschoot P, Van Houtte F, Roobrouck A, Farhoudi A, Leroux-Roels G (2002) Hepatitis B virus surface antigen suppresses the activation of monocytes through interaction with a serum protein and a monocyte-specific receptor. J Gen Virol 83: 1281-1289. (Pubitemid 34591321)
32. Seeger C, Mason WS (2000) Hepatitis B virus biology. Microbiol Mol Biol Rev 64: 51-68. (Pubitemid 30143840)
33. Gehring AJ, Haniffa M, Kennedy PT, Ho ZZ, Boni C, et al. (2013) Mobilizing monocytes to cross-present circulating viral antigen in chronic infection. J Clin Invest 123: 3766-3776.
34. Vanlandschoot P, Van Houtte F, Roobrouck A, Farhoudi A, Stelter F, et al. (2002) LPS-binding protein and CD14-dependent attachment of hepatitis B surface antigen to monocytes is determined by the phospholipid moiety of the particles. J Gen Virol 83: 2279-2289. (Pubitemid 34993735)